News
September 9, 2020
TScan Announces Targets for Two Planned INDs in 2021 to Treat Liquid Tumors
July 28, 2020
TScan Announces Discovery of Precise T Cell Targets in COVID-19 Convalescent Patients to Inform Development of Next-generation Vaccines and T Cell-based Diagnostics
April 15, 2020
TScan Announces Collaboration with Novartis on the Discovery and Development of Novel T Cell Receptor Therapies for the Treatment of Solid Tumors
March 19, 2020
TScan Leveraging Its Platform to Understand T Cell Response to Coronavirus
Seeking Clinical/Translational Collaborators
March 10, 2020
TScan Strengthens Board of Directors with Appointment of Douglas Fambrough, Ph.D.
January 9, 2020
Astellas Venture Management, Pitango Venture Capital and Novartis Institutes for BioMedical Research Lead TScan Series B
December 9, 2019
TScan Founders Lea Hachigian and Tomasz Kula Named in Forbes 2020 “30 Under 30” List
August 12, 2019
TScan Therapeutics Announces Pioneering Publication in Scientific Journal Cell Describing New Methods to Identify Targets for T Cell Receptor Immunotherapy
July 24, 2019